News and Press Releases
ICR scientists seek new drugs to treat childhood cancer as part of global Cancer Grand Challenges team
6 March 2024 -- London, UK -- A global, interdisciplinary team of researchers has been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle...
Category: Clinical Trials, Pharmaceutical
Posted: March 6, 2024
Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes
5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...
Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024
Exonate first-in-class eye drop phase 1b/2a trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema
EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications Data generated fully supports continued clinical development of EXN407...
Category: Clinical Trials
Posted: March 5, 2024
Audion Therapeutics and the REGAIN Consortium Announce Publication in Nature Communications of Their Phase 1/2a Trial of an Intratympanic Gamma Secretase Inhibitor for the Treatment of Mild to Moderate Sensorineural Hearing Loss
The phase 1 part of the study (Multiple Ascending Dose of 3 administrations) confirms safety and tolerability of a dose of 250 microgram of Gamma Secretase Inhibitor LY3056480 Pre-defined Primary...
Category: Clinical Trials
Posted: March 4, 2024
Linnaeusparkweg 10-2, 1098 EA Amsterdam, Netherlands
SolasCure Publishes Phase 2a Clinical Trial Report in Leading Wound Care Journal
Publication in the ‘International Wound Journal’ provides robust validation of the phase 2a trial data that will enable further clinical studies Study demonstrates proof-of-concept and strong safety profile of Aurase...
Category: Biotechnology
Posted: March 4, 2024
WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges
4 March 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the expansion of its capabilities with the...
Category: Clinical Trials
Posted: March 4, 2024
Aotearoa Clinical Trials Becomes First Site in New Zealand to Achieve both GCSA Certification and Silver Workforce Quality Accreditation
Certifications demonstrate Aotearoa Clinical Trials is working to the highest global best-practice standards, ratified by the industry 21 February 2024 -- Auckland, New Zealand and Maidenhead, UK -- Aotearoa Clinical Trials...
Category: Clinical Trials
Posted: February 21, 2024
Esme Green Building Middlemore Hospital 100 Hospital Rd Papatoetoe, 2025 Auckland, New Zealand
Principal IRB Becomes Univo IRB With Support From QHP Capital
20 February 2024 -- North Carolina -- Today, Univo IRB was announced as the new company name for Principal IRB. Univo IRB is a next generation institutional review board (IRB) recently acquired...
Category: Clinical Trials
Posted: February 20, 2024
First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase 1 first-in-human clinical trial
Developed in-house by VHIO-born spin-off company Peptomyc, OMO-103 is a mini-protein targeting the MYC oncogene which is found deregulated in most, if not all tumor types. Until recently, MYC has...
Category: Drug Discovery
Posted: February 7, 2024
Greenphire Announces Acquisition of Clincierge to Enhance Clinical Trial Support Services
Addition enables sponsors to solve the number one clinical trial participant obstacle – transportation, with a single industry-leading solution 1 February 2024 -- Pennsylvania, US -- Greenphire, a leading innovator in...
Category: Clinical Trials
Posted: February 1, 2024
Almost half of Brits think the Government is doing too little to encourage development of new medicines in the UK
25 January -- London, UK -- Recent YouGov polling commissioned by clinical trials start-up Lindus Health has found that 47% of Brits want the Government to be doing more to...
Category: Pharmaceutical
Posted: January 25, 2024
Recipharm, Medspray and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
Partnership will help bring breakthroughs in the nasal delivery of fragile biologics and small molecules to market 23 January 2023 -- Stockholm, Sweden -- Recipharm, a leading contract development and...
Category: Drug Delivery
Posted: January 23, 2024
Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Globally operating CDMO committed to strengthening Germany as a research and production location Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and...
Category: Biotechnology, Pharmaceutical
Posted: January 17, 2024
Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year
Annual analysis of data from 95 million patients shows signs of post-pandemic recovery for clinical development industry, but trial cancellation rates at phase 2 remain high 16 January 2024 --...
Category: Clinical Trials
Posted: January 16, 2024
Headlands Research Announces Partnership with Sahara Behavioral Health
The collaboration improves access to clinical research and investigational treatments while supporting participant recruitment efforts in Arizona 4 January 2024 -- California, US -- Headlands Research, a leading multinational network...
Category: Clinical Trials
Posted: January 5, 2024
